122 related articles for article (PubMed ID: 14724434)
1. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.
Tsai MK; Ho HN; Chien HF; Ou-Yang P; Lee CJ; Lee PH
Transplantation; 2004 Jan; 77(1):48-54. PubMed ID: 14724434
[TBL] [Abstract][Full Text] [Related]
2. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
[TBL] [Abstract][Full Text] [Related]
3. Multiple negative feedbacks on CD152 expression in allograft tolerance.
Tsai MK; Ho HN; Chien HF; Tzeng MC; Chen CH; Lee PH
Transplantation; 2005 Jan; 79(2):174-81. PubMed ID: 15665765
[TBL] [Abstract][Full Text] [Related]
4. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
5. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.
Nakajima A; Azuma M; Kodera S; Nuriya S; Terashi A; Abe M; Hirose S; Shirai T; Yagita H; Okumura K
Eur J Immunol; 1995 Nov; 25(11):3060-9. PubMed ID: 7489744
[TBL] [Abstract][Full Text] [Related]
6. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K
Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826
[TBL] [Abstract][Full Text] [Related]
8. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
[TBL] [Abstract][Full Text] [Related]
9. Graft vasculopathy and tolerance: does the balance of Th cells contribute to graft vasculopathy?
Hamano K; Bashuda H; Ito H; Shirasawa B; Okumura K; Esato K
J Surg Res; 2000 Sep; 93(1):28-34. PubMed ID: 10945940
[TBL] [Abstract][Full Text] [Related]
10. Blockade of CD80 and CD86 at the time of implantation inhibits maternal rejection to the allogeneic fetus in abortion-prone matings.
Jin LP; Zhou YH; Wang MY; Zhu XY; Li DJ
J Reprod Immunol; 2005 Apr; 65(2):133-46. PubMed ID: 15811518
[TBL] [Abstract][Full Text] [Related]
11. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
12. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
13. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands.
Lal RB; Rudolph DL; Dezzutti CS; Linsley PS; Prince HE
J Immunol; 1996 Aug; 157(3):1288-96. PubMed ID: 8757637
[TBL] [Abstract][Full Text] [Related]
14. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
Wang J; Zhang L; Tang J; Jiang S; Wang X
Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
[TBL] [Abstract][Full Text] [Related]
15. Graded function of CD80 and CD86 in initiation of T-cell immune response and cardiac allograft survival.
Xiang J; Gu X; Qian S; Chen Z
Transpl Int; 2008 Feb; 21(2):163-8. PubMed ID: 17971032
[TBL] [Abstract][Full Text] [Related]
16. Blockade of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) down-regulates induction of contact sensitivity by haptenated epidermal cells.
Katayama I; Matsunaga T; Yokozeki H; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):846-52. PubMed ID: 9217815
[TBL] [Abstract][Full Text] [Related]
17. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
[No Abstract] [Full Text] [Related]
18. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
Mukherjee S; Ahmed A; Malu S; Nandi D
J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
[TBL] [Abstract][Full Text] [Related]
19. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
Vierboom MP; Ossevoort M; Sick EA; Haanstra K; Jonker M
Transpl Immunol; 2003; 11(2):215-22. PubMed ID: 12799206
[TBL] [Abstract][Full Text] [Related]
20. B7.2 (CD86) but not B7.1 (CD80) costimulation is required for the induction of low dose oral tolerance.
Liu L; Kuchroo VK; Weiner HL
J Immunol; 1999 Aug; 163(4):2284-90. PubMed ID: 10438973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
